Literature DB >> 6153302

Angiotensin-converting enzyme in human prostate.

M Yokoyama, K Hiwada, T Kokubu, M Takaha, M Takeuchi.   

Abstract

The activity of angiotensin-converting enzyme in human prostate was measured by spectrophotometric method using Hippuryl-L-histidyl-L-leucine (Hip-His-Leu) as substrate. Benign hypertrophic prostate had significantly higher concentration of angiotensin-converting enzyme (1.99 +/- 0.36 (S.E.M.) units/g of tissue, n = 13) than normal prostate (0.44 +/- 0.1 units/g of tissue, n = 5) (p less than 0.01). More than 80% of the enzyme activity occurred in soluble fraction of normal and hypertrophied prostates. Human prostatic angiotensin-converting enzyme, partially purified from benign hypertrophic prostates, had an apparent molecular weight of 290,000 and pI of 4.1. Optimum pH of the enzyme with KM value of 1.0 mmol/l was 7.8 in 0.1 mmol/l borate/sodium/carbonate buffer. The enzyme was competitively inhibited by captopril (Ki, 1.8 nmol/l).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153302     DOI: 10.1016/0009-8981(80)90274-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Immunolocalization of angiotensin 1 converting enzyme in the human male genital tract by the avidin-biotin-complex method.

Authors:  F Vivet; P Callard; A Gamoudi
Journal:  Histochemistry       Date:  1987

2.  Tissue Specificity of Human Angiotensin I-Converting Enzyme.

Authors:  Olga V Kryukova; Victoria E Tikhomirova; Elena Z Golukhova; Valery V Evdokimov; Gavreel F Kalantarov; Ilya N Trakht; David E Schwartz; Randal O Dull; Alexander V Gusakov; Igor V Uporov; Olga A Kost; Sergei M Danilov
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

3.  Tissue ACE phenotyping in prostate cancer.

Authors:  Sergei M Danilov; Alexey V Kadrev; Olga V Kurilova; Victoria E Tikhomirova; Olga V Kryukova; Vadim N Mamedov; David M Kamalov; Natalia V Danilova; Dmitry A Okhobotov; Nurshat M Gayfullin; Valery V Evdokimov; Boris J Alekseev; Olga A Kost; Larisa M Samokhodskaya; Armais A Kamalov
Journal:  Oncotarget       Date:  2019-10-29

4.  Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way.

Authors:  Mengyang Zhang; Dongxu Lin; Changcheng Luo; Pengyu Wei; Kai Cui; Zhong Chen
Journal:  Oxid Med Cell Longev       Date:  2022-02-01       Impact factor: 6.543

5.  Effect of COVID-19 on Male Reproductive System - A Systematic Review.

Authors:  Yanfei He; Jie Wang; Junlin Ren; Yubo Zhao; Jing Chen; Xuejiao Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-27       Impact factor: 5.555

6.  The absence of coronavirus in expressed prostatic secretion in COVID-19 patients in Wuhan city.

Authors:  Shiqi Zhang; Xiaobo Wang; Hong Zhang; Aihui Xu; Guanghe Fei; Xiao Jiang; Jun Tu; Guangbo Qu; Xihai Xu; Yonghuai Li
Journal:  Reprod Toxicol       Date:  2020-06-10       Impact factor: 3.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.